JESSICA CARDEN: Open Payments
NPI 1487138400 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$304 in 10 payments from 6 companies in 2025. Trend: 2023 $789 · 2024 $515 · 2025 $304
Food & beverage: $304
| Company | Payments | Amount |
|---|---|---|
| Alpha Cognition USA, Inc. | 2 | $135 |
| Neurocrine BioSciences, Inc. | 2 | $45 |
| Novartis Pharmaceuticals Corporation | 2 | $34 |
| Teva Pharmaceuticals USA, Inc. | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| ABBVIE INC. | 1 | $28 |
Products named: Zunveyl, INGREZZA, Fabhalta, AUSTEDO XR, REXULTI, VENCLEXTA.
Industry payments across FL — which companies pay providers there.
